Mutant Prevention Concentrations of Fluoroquinolones for Enterobacteriaceae Expressing the Plasmid-Carried Quinolone Resistance Determinant qnrA1

Por Rodríguez-Martínez, J. M., Velasco, C., García, I., Cano, M. E., Martínez-Martínez, L., Pascual, A.
Publicado em 2007

In Vitro Effect of qnrA1, qnrB1, and qnrS1 Genes on Fluoroquinolone Activity against Isogenic Escherichia coli Isolates with Mutations in gyrA and parC

Por Briales, A., Rodríguez-Martínez, J. M., Velasco, C., Díaz de Alba, P., Domínguez-Herrera, J., Pachón, J., Pascual, A.
Publicado em 2011

Urinary Tract Conditions Affect Fosfomycin Activity against Escherichia coli Strains Harboring Chromosomal Mutations Involved in Fosfomycin Uptake

Por Martín-Gutiérrez, G., Docobo-Pérez, F., Rodriguez-Beltrán, J., Rodríguez-Martínez, J. M., Aznar, J., Pascual, A., Blázquez, J.
Publicado no Antimicrob Agents Chemother (2017)

Detection of Plasmid-Mediated Quinolone Resistance Genes in Clinical Isolates of Enterobacter spp. in Spain

Por Cano, M. E., Rodríguez-Martínez, J. M., Agüero, J., Pascual, A., Calvo, J., García-Lobo, J. M., Velasco, C., Francia, M. V., Martínez-Martínez, L.
Publicado em 2009

Quinolone Resistance Reversion by Targeting the SOS Response

Por Recacha, E., Machuca, J., Díaz de Alba, P., Ramos-Güelfo, M., Docobo-Pérez, F., Rodriguez-Beltrán, J., Blázquez, J., Pascual, A., Rodríguez-Martínez, J. M.
Publicado no mBio (2017)

Pharmacodynamics of Fosfomycin: Insights into Clinical Use for Antimicrobial Resistance

Por Docobo-Pérez, F., Drusano, G. L., Johnson, A., Goodwin, J., Whalley, S., Ramos-Martín, V., Ballestero-Tellez, M., Rodriguez-Martinez, J. M., Conejo, M. C., van Guilder, M., Rodríguez-Baño, J., Pascual, A., Hope, W. W.
Publicado no Antimicrob Agents Chemother (2015)